A detailed history of Jump Financial, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Jump Financial, LLC holds 21,573 shares of URGN stock, worth $342,579. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,573
Previous 33,320 35.26%
Holding current value
$342,579
Previous $499,000 35.27%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.81 - $19.33 $162,226 - $227,069
-11,747 Reduced 35.26%
21,573 $323,000
Q4 2023

Feb 07, 2024

BUY
$10.87 - $15.93 $40,436 - $59,259
3,720 Added 12.57%
33,320 $499,000
Q3 2023

Nov 07, 2023

BUY
$8.84 - $22.64 $261,664 - $670,144
29,600 New
29,600 $414,000
Q4 2021

Feb 10, 2022

SELL
$9.03 - $19.13 $94,815 - $200,865
-10,500 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$14.31 - $18.39 $150,255 - $193,095
10,500 New
10,500 $177,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $361M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.